As outlined in the 2022-2027 Strategic Plan, the St. Jude Research Collaboratives program is part of an overall effort by the institution to fund collaborative
Advances in pediatric cancer research and treatment over the past 50 years have led to dramatic improvements in survival outcomes for this vulnerable population.There is always room for further progress, however, particularly in the development of more targeted, less toxic therapies.
Greg Armstrong, MD, MSCE, has been named chair of the department of epidemiology and cancer control at St. Jude Children’s Research Hospital.Armstrong — a Healio | HemOnc Today Editorial Board member — is recognized for his expertise in childhood cancer survivorship.
Large-scale collaboration will leverage each institution’s expertise and infrastructure to advance understanding of the biological basis of pediatric.